Taro gets generic Zyrtec go-ahead
This article was originally published in The Tan Sheet
Executive Summary
FDA approves the Hawthorne, N.Y.-based company's abbreviated new drug application for 5-mg and 10-mg cetirizine hydrochloride tablets. Taro Pharmaceuticals said July 27 it previously received approval for an equivalent of Johnson & Johnson/McNeil's Children's Zyrtec Oral Solution (1"The Tan Sheet" April 28, 2008, In Brief). FDA has already approved private-label versions of the OTC allergy drug manufactured by Perrigo, Sandoz, Ranbaxy and Mylan